Jenny about … Do Something Good and Talk About It!
“Airplanes and medicines are dangerous”: This is the perception of a large part of the population of the Western world.
Is it the high profits of manufacturers? Is it the incomprehensible complexity of production and efficacy? Pharmaceutical and medical device companies invest considerable resources in quality assurance. Globally the GxP and CE regulation are nowadays implemented as recognized standards, albeit with varying intensity. Life science companies in Switzerland have succeeded in entrenching quality assurance as a pervasive culture in all their procedures and processes, as well as in the minds of their employees. It is a pity that this success story is not conveyed to the patients more effectively. I remember an experience I had as part of a co-inspection with Canadian inspectors at a Swiss company. The team of inspectors was accompanied by an external interpreter. On the way back to Basel she spontaneously said: “I could never have imagined that companies would be inspected so vigorously and down to the very last detail. This has drastically increased my confidence in the products.” So, what actually prevents us from providing the general public with a similarly eye-opening “Aha experience” as we saw with the interpreter?
■ Dr. Hans-Beat Jenny
Dr. Hans-Beat Jenny is an expert on GxP matters and has decades of industry experience. For a long time, the chemist with a doctorate degree had been involved in the research and quality assurance of a Basel pharmaceutical company, before taking over management of the Drug Inspection Agency of Northwestern Switzerland and later the Sector Licensing of Swissmedic. The former Deputy Director of Swissmedic has been working as a consultant since his retirement in 2016.